US to hike fees for generic drugmakers, Indian firms to be hit

Aug 11 2013, 14:58 IST
Comments 0
India is the second largest drug exporter to the US, according to the Food and Drug Administration. (AP) India is the second largest drug exporter to the US, according to the Food and Drug Administration. (AP)
SummaryIndia is the second largest drug exporter to the US, according to the Food and Drug Administration.

and foreign API facilities.

FDA says that these fees help it reduce the backlog of pending applications, cut the average time required to review generic drug applications for safety, and improve the risk-based inspections.

Single Page Format
Ads by Google

More from Business

Reader´s Comments
| Post a Comment
Please Wait while comments are loading...